Safety and Tolerability of Dexmecamylamine (TC-5214) Adjunct to Ongoing Antidepressant Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy-Reference-Cited by-同舟云学术

Safety and Tolerability of Dexmecamylamine (TC-5214) Adjunct to Ongoing Antidepressant Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy

Published:2015-02 Issue:1 Volume:35 Page:77-81
ISSN:0271-0749
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:

Author:

Tummala Raj,Desai Dhaval,Szamosi Johan,Wilson Ellis,Hosford David,Dunbar Geoffrey,Eriksson Hans

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference10 articles.

1. Prevalence and management of treatment-resistant depression.;Nemeroff;J Clin Psychiatry,2007

2. Limitations in efficacy of antidepressant monotherapy.;Rush;J Clin Psychiatry,2007

3. Pharmacologic characteristics of ideal antidepressants in the 21st century.;DeVane;J Clin Psychiatry,2000

4. TC-5214 (S-()-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity.;Lippiello;CNS Neurosci Ther,2008

5. Population pharmacokinetics of TC-5214, a nicotinic channel modulator, in phase I and II clinical studies.;Xu;J Clin Pharmacol,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydroxynorketamine, but not ketamine, acts via α7 nicotinic acetylcholine receptor to control presynaptic function and gene expression;Translational Psychiatry;2024-01-22

2. The boundlessness of behavioral neuroscience: A look across 30 years;Neuroscience & Biobehavioral Reviews;2022-11

3. Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: pharmacological, behavioral, and neurochemical characterization;Psychopharmacology;2022-03-17

4. Drug Repurposing for the Management of Depression: Where Do We Stand Currently?;Life;2021-07-30

5. Discovery and Development of 3-(6-Chloropyridine-3-yloxymethyl)-2-azabicyclo[3.1.0]hexane Hydrochloride (SUVN-911): A Novel, Potent, Selective, and Orally Active Neuronal Nicotinic Acetylcholine α4β2 Receptor Antagonist for the Treatment of Depression;Journal of Medicinal Chemistry;2020-02-06